GlassScriptPhysician profile
David Fernandez
NPI 1932139375
$1,745.04
in general payments reported to CMS, 2019-2025
11 companies · $243 in 2025
The $243 reported for 2025 was more than what a typical Pediatric Gastroenterology provider received nationally (typical 2025 total: $195).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2021: $321 · 2022: $208 · 2023: $494 · 2024: $347 · 2025: $243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,084.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,083.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $400.14 | 2022-2025 | |
| Abbvie INC. | $308.29 | 2019-2021 | |
| Mirum Pharmaceuticals, INC. | $244.06 | 2024 | Livmarli |
| E.R. Squibb & Sons, L.L.C. | $127.14 | 2023 | Zeposia |
| Janssen Scientific Affairs, LLC | $125.00 | 2021 | |
| Albireo Pharma, INC. | $122.03 | 2023 | Bylvay |
| Ipsen Biopharmaceuticals, INC | $117.87 | 2025 | Bylvay |
| Takeda Pharmaceuticals U.S.A., INC. | $105.88 | 2022 | |
| Janssen Pharmaceuticals, INC | $98.28 | 2023 | Stelara |
| Genentech, INC. | $76.84 | 2024 | Xolair |
| Pbg Puerto Rico LLC | $19.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Fernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.